Photophysics of Photodynamic Therapy
Photophysics of Photodynamic Therapy
批准号:
7475898
负责人:
THOMAS Harrison FOSTER
金额:
$32.3万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
1995
资助国家:
美国
项目状态:
已结题
起止时间:
1995-07-01 至 2012-05-31
关键词:
AccountingAddressAreaBiologicalCancerousCell Adhesion MoleculesCell surfaceCellsClinicClinicalClinical TreatmentClinical TrialsCommunitiesComplexConditionConsumptionDataDepositionDepthDevicesDiffuseDoseEffectivenessFiberFluorescence MicroscopyFluorescence SpectroscopyFundingGene ExpressionGrantHPPHHeat-Shock Proteins 70HeterogeneityHumanImageImmuneImmune responseIn VitroInvasiveInvestigationKidneyKineticsLaboratoriesLaboratory FindingLaboratory StudyLasersLevulanLightMalignant NeoplasmsMeasurementMeasuresMethodsMicroscopicModelingMolecularMonitorMusNeedlesNew AgentsNumbersOpticsOxygenPatternPharmaceutical PreparationsPhotochemotherapyPhotosensitizing AgentsPlayPorfimer SodiumPropertyProteinsProtocols documentationPublic HealthRenal Cell CarcinomaReporterReportingResearchResearch DesignScanningSolid NeoplasmSpecimenSpectrum AnalysisSurfaceTechniquesTemoporfinTimeTissuesTranslatingTreatment FailureUnited StatesVerteporfinbasedosimetryfluorescence imagingimprovedin vivointerestinterstitialmathematical modelmicrospectrofluorimetrymolecular imagingmonoaspartyl chlorin e6neoplastic celloxygen transportpreclinical studyresearch clinical testingresponsesuccesstooltumor
中文摘要
描述(由申请人提供):光动力疗法(PDT)的癌症和其他条件继续获得临床认可。三种光敏药物Photofrin,Visudyne和Levulan在美国的批准以及世界各地对几种有前途的新药的持续临床评估为正在进行的旨在进一步了解和优化这种疗法的实验室研究提供了背景。在过去的几年中,该领域已经获得了更深层次的理解光敏药物,光,和氧气,共同定义PDT的剂量之间的复杂和动态的相互作用。十多年来,在这个实验室的研究已经证明了存在,并强调在肿瘤中的氧和光敏剂的微观梯度的后果,探索了几种形式的光谱学和成像作为监测光动力剂量沉积和评估生物反应PDT的手段,最近,进行了使用荧光报告成像PDT诱导的基因表达在体内。上一个供资周期取得的进展为在这些问题和密切相关的问题上取得进一步重大进展创造了一些机会。为了达到这些总体目标,本申请提出了以下三个具体目标:(1)进一步扩展光敏剂浓度、氧可用性和剂量沉积中微观异质性的实验研究和理论分析;(2)利用分子成像策略来确定肿瘤对PDT反应的异质性,并开发控制免疫反应募集机制的成像方法;(3)测量人肾细胞癌和正常肾组织的光学特性,探索建立图像引导的间质PDT治疗深部肿瘤的方法。将用于实现这些目标的实验方法包括激光扫描光学切片荧光显微镜和显微荧光光谱法,整个小鼠体内荧光成像和光谱,漫反射光谱。与公共卫生的相关性:光动力疗法被批准用于治疗几种癌症和癌前疾病。随着我们更全面地了解限制其有效性的因素并将研究结果从实验室转化为临床,它的潜力将得到更充分的实现。本补助金中提出的研究解决了这两个目标。
英文摘要
DESCRIPTION (provided by applicant): Photodynamic therapy (PDT) of cancer and of other conditions continues to gain clinical acceptance. The approvals of three photosensitizing drugs, Photofrin, Visudyne, and Levulan, in the United States and the ongoing clinical evaluation of several promising new agents throughout the world provide the context for ongoing laboratory studies that are designed to understand further and to optimize this therapy. During the past several years, the field has gained a deeper appreciation of the complex and dynamic interactions among the photosensitizing drug, light, and oxygen that together define the dosimetry of PDT. For more than a decade, research in this laboratory has demonstrated the existence and emphasized the consequences of microscopic gradients of oxygen and of photosensitizer in tumors, explored several forms of optical spectroscopy and imaging as means of monitoring photodynamic dose deposition and evaluating biological response to PDT, and more recently, undertaken the use of fluorescent reporters to image PDT-induced gene expression in vivo. Progress during the previous funding cycle has created a number of opportunities to make further significant progress on these and closely related problems. Toward these general ends, the application poses the following three specific aims: (1) to further expand the experimental investigation and theoretical analysis of microscopic heterogeneities in photosensitizer concentration, oxygen availability, and dose deposition; (2) to exploit molecular imaging strategies to determine heterogeneities in tumor response to PDT and to develop means of imaging the mechanisms governing the recruitment of immune responses; and (3) to measure optical properties of human renal cell carcinoma and of normal kidney and to explore means of further establishing image-guided, interstitial PDT for deep tumors. The experimental methods that will be used to accomplish these aims include laser scanning optical sectioning fluorescence microscopy and microspectrofluorimetry, whole mouse fluorescence imaging and spectroscopy in vivo, and diffuse reflectance spectroscopy. Relevance to public health: Photodynamic therapy is approved for the treatment of several cancers and pre-cancerous conditions. Its potential will be more fully realized as we understand more completely the factors that limit its effectiveness and translate findings from the laboratory to the clinic. Studies proposed in this grant address both of these objectives.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Optics
-
批准号:8230227
-
项目类别:
-
资助金额:$15.48万
-
财政年份:2011
-
负责人:THOMAS Harrison FOSTER
-
依托单位:
Optics
-
批准号:7611650
-
项目类别:
-
资助金额:$19.41万
-
财政年份:2008
-
负责人:THOMAS Harrison FOSTER
-
依托单位:
Optical Dosimetry for Clinical Trials of Pc 4 Photodynamic Therapy
-
批准号:7844929
-
项目类别:
-
资助金额:$24.2万
-
财政年份:2006
-
负责人:THOMAS Harrison FOSTER
-
依托单位:
Optical Dosimetry for Clinical Trials of Pc 4 Photodynamic Therapy
-
批准号:7254804
-
项目类别:
-
资助金额:$24.2万
-
财政年份:2006
-
负责人:THOMAS Harrison FOSTER
-
依托单位:
Optical Dosimetry for Clinical Trials of Pc 4 Photodynamic Therapy
-
批准号:7129375
-
项目类别:
-
资助金额:$24.92万
-
财政年份:2006
-
负责人:THOMAS Harrison FOSTER
-
依托单位:
Optical Dosimetry for Clinical Trials of Pc 4 Photodynamic Therapy
-
批准号:7629147
-
项目类别:
-
资助金额:$24.2万
-
财政年份:2006
-
负责人:THOMAS Harrison FOSTER
-
依托单位:
Optical Dosimetry for Clinical Trials of Pc 4 Photodynamic Therapy
-
批准号:7426441
-
项目类别:
-
资助金额:$24.2万
-
财政年份:2006
-
负责人:THOMAS Harrison FOSTER
-
依托单位:
PHOTOPHYSICS OF NILE BLUE PHOTODYNAMIC THERAPY
-
批准号:2700632
-
项目类别:
-
资助金额:$14.86万
-
财政年份:1995
-
负责人:THOMAS Harrison FOSTER
-
依托单位:
Photophysics of Photodynamic Therapy
-
批准号:7010700
-
项目类别:
-
资助金额:$32.27万
-
财政年份:1995
-
负责人:THOMAS Harrison FOSTER
-
依托单位:
Photophysics of Photodynamic Therapy
-
批准号:6846853
-
项目类别:
-
资助金额:$33.04万
-
财政年份:1995
-
负责人:THOMAS Harrison FOSTER
-
依托单位:
PHOTOPHYSICS OF NILE BLUE PHOTODYNAMIC THERAPY
-
批准号:2112365
-
项目类别:
-
资助金额:$14.36万
-
财政年份:1995
-
负责人:THOMAS Harrison FOSTER
-
依托单位:
Photophysics of Photodynamic Therapy
-
批准号:6580687
-
项目类别:
-
资助金额:$36.61万
-
财政年份:1995
-
负责人:THOMAS Harrison FOSTER
-
依托单位:
PHOTOPHYSICS OF PHOTODYNAMIC THERAPY
-
批准号:6512771
-
项目类别:
-
资助金额:$28.66万
-
财政年份:1995
-
负责人:THOMAS Harrison FOSTER
-
依托单位:
PHOTOPHYSICS OF NILE BLUE PHOTODYNAMIC THERAPY
-
批准号:2112364
-
项目类别:
-
资助金额:$15.9万
-
财政年份:1995
-
负责人:THOMAS Harrison FOSTER
-
依托单位:
PHOTOPHYSICS OF PHOTODYNAMIC THERAPY
-
批准号:6164198
-
项目类别:
-
资助金额:$26.53万
-
财政年份:1995
-
负责人:THOMAS Harrison FOSTER
-
依托单位:
Photophysics of Photodynamic Therapy
-
批准号:7835798
-
项目类别:
-
资助金额:$32.3万
-
财政年份:1995
-
负责人:THOMAS Harrison FOSTER
-
依托单位:
PHOTOPHYSICS OF NILE BLUE PHOTODYNAMIC THERAPY
-
批准号:2414416
-
项目类别:
-
资助金额:$14.3万
-
财政年份:1995
-
负责人:THOMAS Harrison FOSTER
-
依托单位:
PHOTOPHYSICS OF PHOTODYNAMIC THERAPY
-
批准号:6362598
-
项目类别:
-
资助金额:$27.83万
-
财政年份:1995
-
负责人:THOMAS Harrison FOSTER
-
依托单位:
Photophysics of Photodynamic Therapy
-
批准号:8073508
-
项目类别:
-
资助金额:$31.33万
-
财政年份:1995
-
负责人:THOMAS Harrison FOSTER
-
依托单位:
PHOTOPHYSICS OF PHOTODYNAMIC THERAPY
-
批准号:2842064
-
项目类别:
-
资助金额:$29.58万
-
财政年份:1995
-
负责人:THOMAS Harrison FOSTER
-
依托单位:
海外基金